Marilin Rosa
YOU?
Author Swipe
View article: Interobserver Variability in the Measurement of the Metastatic Tumor Size on Breast Sentinel Lymph Nodes
Interobserver Variability in the Measurement of the Metastatic Tumor Size on Breast Sentinel Lymph Nodes Open
Context.— Accurate measurement of breast cancer metastatic deposits in sentinel lymph nodes (SLNs) can be challenging despite the presence of guidelines. Objective.— To assess interobserver variability in measuring metastatic breast carcin…
View article: Table S19 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S19 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 19: Summary of number of PR-stained cores per patient (by cohort).
View article: Table S15 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S15 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 15: Summary of PAM50 types by HR/HER2 status and cohort.
View article: Table S9 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S9 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 9: Comparison of derived Clinical HR calls vs. derived TMA stain evaluations.
View article: Figure S2 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Figure S2 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Figure 2
View article: Table S13 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S13 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 13: Summary of risk categorizations Ki-67 across cohorts.
View article: Table S2 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S2 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 2: Outcomes for ME-BRTMA by cohort.
View article: Figure S4 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Figure S4 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Figure 4
View article: Table S4 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S4 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 4: The antibodies used for immunohistochemistry.
View article: Table S20 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S20 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 20: Agreement of tumor cores HER2 scores for same patient in TMA.
View article: Figure S1 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Figure S1 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Figure 1
View article: Table S16 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S16 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 16: Agreement of ER scores of tumor cores for same patient in TMA.
View article: Figure 3 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Figure 3 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
TNBC is most common in the NHB cohort. A, Stacked bar chart showing the fraction of patients with each level of HER2 expression among the four cohorts (P = 0.387, χ2 test). B, Stacked bar chart showing that …
View article: Table S7 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S7 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 7: Comparison of Clinical ER calls vs. TMA stain evaluations (simplified).
View article: Table S6 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S6 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 6: Analysis of all IHC scoring values of the 371 tumor cores on the TMA by cohort.
View article: Table S3 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S3 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 3: Summary of all 610 cores of the TMA.
View article: Data from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Data from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Breast cancer is a leading cause of cancer-related mortality among women worldwide and is known to have higher mortality among women with African ancestry. Herein, we describe the creation and characterization of a multiethnic breast cance…
View article: Table S11 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S11 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 11: Summary of HR/HER2 stain evaluation by cohort.
View article: Figure 5 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Figure 5 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
PAM50 analysis shows that basal-like subtype is most frequent among NHBs. Stacked bar chart shows the results of PAM50 gene expression analysis on patients represented on the ME-BrTMA with available RNA sequencing data. The data show that …
View article: Table S17 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S17 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 17: Summary of number of ER-stained cores per patient (by cohort)
View article: Table S8 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S8 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 8: Comparison of Clinical PR calls vs. TMA stain evaluations.
View article: Figure S5 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Figure S5 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Figure 5
View article: Figure S3 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Figure S3 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Figure 3
View article: Table S10 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S10 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 10: Comparison of Clinical HER2 calls vs. TMA stain evaluations.
View article: Table S12 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S12 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 12: Comparison of derived Clinical HR/HER2 calls vs. TMA stain evaluations.
View article: Table S21 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S21 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 21: Summary of number of HER2-stained cores per patient (by cohort).
View article: Table S1 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S1 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 1: Analysis of basic clinical and data regarding each cohort.
View article: Figure 4 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Figure 4 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
High expression of the proliferative marker Ki-67 is more frequent among cores from the NHB cohort. A, Boxplots comparing Ki-67% positivity as a function of the cohort. B, Risk categories for Ki-67 (low risk, 14 PPN) are show…
View article: Table S5 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S5 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 5: IHC scoring values of the 371 tumor cores on the TMA.
View article: Table S14 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida
Table S14 from Creation and Characterization of a Breast Cancer Tissue Microarray Including Black and White Patients from Florida and Hispanic Patients from Puerto Rico and Florida Open
Supplementary Table 14: Summary of PAM50 by cohort.